Dr. Tomlinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3951
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
Case Western Reserve University School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - Present
OH State Medical License 2015 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies Start of enrollment: 2020 Nov 16
Roles: Contact, Sponsor-Investigator
- Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant Start of enrollment: 2024 Oct 01
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- 62 citationsDecitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.Xiaorong Gu, Rita Tohme, Benjamin Tomlinson, Nneha Sakre, Metis Hasipek
Leukemia. 2021-04-01 - 11 citationsClonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.Audrey N. Jajosky, Navid Sadri, Howard J. Meyerson, Kwadwo A. Oduro, Ashwin Kelkar
European Journal of Haematology. 2021-01-01 - 8 citationsBiosimilar strategic implementation at a large health system.Indrani Kar, Margaret Kronz, Evelina Kolychev, Paula Silverman, Prateek Mendiratta
American Journal of Health-System Pharmacy. 2021-11-09
Abstracts/Posters
- Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk PredictionBenjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...Benjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-AzacytidineBenjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
